Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.49 |
| ▸ | GDA | Q9Y2T3 | 3/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | XDH | P47989 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.37 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.37 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenyl Dihydrogen Phosphate SCHEMBL1711873 | 0.76 | SRC (0.47) | MAPTADORA2BXDHALDH1A1HSD17B10 | |
| SCHEMBL9515047 | 0.75 | MAPT (0.50) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL30537976 | 0.74 | ALDH1A1 (0.60) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL2837685 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| Uric Acid SCHEMBL30269772 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL932949 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL740931 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL932609 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| Uric Acid SCHEMBL2786719 | 0.74 | MAPT (0.53) | MAPTADORA2BGDAACHEXDH | |
| SCHEMBL447389 | 0.74 | MAPT (0.84) | MAPTADORA2BGDAACHEXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 15797 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747263-A1 | LIPID NANOPARTICLES AND USES THEREOF | University of Connecticut (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4728052-A1 | SYSTEMS AND METHODS OF CELL TRANSPORT AT AMBIENT TEMPERATURE | Bedford Research Foundation (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4363043-B1 | COMPOSITIONS FOR USE IN METHODS FOR INCREASING CANCER CELL SENSITIVITY TO ALTERNATING ELECTRIC FIELDS | NOVOCURE GMBH (CH) | 2026-04-22 | — | — | EP | claimed |
| EP-4719373-A1 | PHOTODYNAMIC THERAPY COMBINATIONS FOR IMPROVEMENT OF ACTINIC KERATOSIS, ACNE AND BASAL CELL CARCINOMA | Alexandroff, Anton (GB) | 2026-04-08 | — | — | EP | claimed |
| US-12594421-B2 | Compositions and methods for increasing cancer cell sensitivity to alternating electric fields | NOVOCURE GMBH (CH) | 2026-04-07 | — | — | US | claimed |
| EP-3521419-B1 | METHOD FOR PRODUCING BROWN ADIPOCYTES AND COMPOSITION | KYOTO PREFECTURAL PUBLIC UNIV CORP (JP) | 2026-03-18 | — | — | EP | claimed |
| US-20260060970-A1 | Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance | MITODICURE GMBH (DE) | 2026-03-05 | — | — | US | claimed |
| US-20260062414-A1 | NOVEL COCRYSTALS OF METHYLXANTHINES, THEIR POLYMORPHS AND PROCESS THEREOF | FERTIS INDIA PVT LTD (IN) | 2026-03-05 | — | — | US | claimed |
| US-20260060949-A1 | METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-03-05 | — | — | US | claimed |
| EP-4696298-A2 | PERSONAL CLEANSING COMPOSITION | Byrne, Daniel (IE) | 2026-02-18 | — | — | EP | claimed |
| US-4753945-A | Stimulation of tear secretion with phosphodiesterase inhibitors | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1988-06-28 | — | — | US | claimed |
| EP-0240511-A1 | AEROSOL | BIOCOMPATIBLES LTD. (GB) | 1987-10-14 | — | — | EP | claimed |
| EP-0234854-A2 | Use of phosphodiesterase inhibitors and cyclic nucleotide analogues for the manufacture of a medicament for stimulating tear secretion | EYE RESEARCH INSTITUTE OF RETINA FOUNDATION (US) | 1987-09-02 | — | — | EP | claimed |
| WO-1987001586-A1 | AEROSOL | BIOCOMPATIBLES LIMITED (GB) | 1987-03-26 | — | — | WO | claimed |
| EP-0213083-A2 | Controlled release tablet | Zyma SA (CH) | 1987-03-04 | — | — | EP | claimed |
| US-4568676-A | SYNERGISTIC INHIBITION | THOMAS JEFFERSON UNIVERSITY (US) | 1986-02-04 | — | — | US | claimed |
| US-4562194-A | BENZOPHENONE COMPOUND IN COMBINATION WITH 3-ISOBUTYL-1-METHYLANTHINE | WARNER-LAMBERT COMPANY (US) | 1985-12-31 | — | — | US | claimed |
| US-4390532-A | MUCOPOLYSACCHARIDES, SHIN DISORDERS | DR. CARL HAHN, G.M.B.H. (DE) | 1983-06-28 | — | — | US | claimed |
| US-4364922-A | ATRIOVENTRICULAR CONDUCTION BLOCK | UNIVERSITY OF VIRGINIA ALUMNI PATENTS FOUNDATION (US) | 1982-12-21 | — | — | US | claimed |
| US-4273774-A | 1,3-DIMETHYL-5-AMINOADMANTANE TOGETHER WITH CAFFEINE OR THEOPHYLLINE | MERZ & CO. (DE) | 1981-06-16 | — | — | US | claimed |